You're reading the free version. Trader adds the live tape and alerts.
Start tracking
INBX Buy Disclosure
Lappe Mark · SEC Form 4 · Filed Oct 14, 2026
Buy
Calculated transaction value
$205.89K
Lappe Mark Chief Executive Officer
INBX
Inhibrx Biosciences
INBX
Transaction date
Oct 14, 2026
Public filing date
Oct 14, 2026
Filing lag
Filed same day
INBX daily price context
Close on/before transaction
$85.26
Oct 14, 2026
First close after public filing
$90.5
Oct 15, 2026
Return after filing · so far
+0.1%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,449 shares @ $84.07
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366074-26-000006
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$848.98K
Buys / sales
6 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX Current | Buy | Oct 14, 2026 | $205.89K |
| Inhibrx Biosciences, Inc. INBX | Buy | Oct 14, 2026 | $8.58K |
| Inhibrx Biosciences, Inc. INBX | Buy | Oct 14, 2026 | $207.65K |
| Inhibrx Biosciences, Inc. INBX | Buy | Oct 14, 2026 | $209.95K |
| Inhibrx Biosciences, Inc. INBX | Buy | Oct 14, 2026 | $208.33K |
| Inhibrx Biosciences, Inc. INBX | Buy | Oct 14, 2026 | $8.58K |